Zhu AX - Search Results

1

Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial.

Verset G, Borbath I, Karwal M, Verslype C, Van Vlierberghe H, Kardosh A, Zagonel V, Stal P, Sarker D, Palmer DH, Vogel A, Edeline J, Cattan S, Kudo M, Cheng AL, Ogasawara S, Daniele B, Chan SL, Knox JJ, Qin S, Siegel AB, Chisamore M, Hatogai K, Wang A, Finn RS, Zhu AX. Verset G, et al. Among authors: zhu ax. Clin Cancer Res. 2022 Jun 13;28(12):2547-2554. doi: 10.1158/1078-0432.CCR-21-3807. Clin Cancer Res. 2022. PMID: 35421228 Free PMC article. Clinical Trial.

2

Hepatocellular carcinoma: are we making progress?

Zhu AX. Zhu AX. Cancer Invest. 2003 Jun;21(3):418-28. doi: 10.1081/cnv-120018233. Cancer Invest. 2003. PMID: 12901288 Review.

3

Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.

Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K, Terella A, Hertl M, Cosimi AB, Chung RT. Leung JY, et al. Among authors: zhu ax. Liver Transpl. 2004 Nov;10(11):1343-54. doi: 10.1002/lt.20311. Liver Transpl. 2004. PMID: 15497158 Free article.

4

A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinoma.

Zhu AX, Fuchs CS, Clark JW, Muzikansky A, Taylor K, Sheehan S, Tam K, Yung E, Kulke MH, Ryan DP. Zhu AX, et al. Oncologist. 2005 Jun-Jul;10(6):392-8. doi: 10.1634/theoncologist.10-6-392. Oncologist. 2005. PMID: 15967833 Free article. Clinical Trial.

5

Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma.

Zhu AX, Blaszkowsky LS, Ryan DP, Clark JW, Muzikansky A, Horgan K, Sheehan S, Hale KE, Enzinger PC, Bhargava P, Stuart K. Zhu AX, et al. J Clin Oncol. 2006 Apr 20;24(12):1898-903. doi: 10.1200/JCO.2005.04.9130. J Clin Oncol. 2006. PMID: 16622265 Clinical Trial.

6

Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?

Zhu AX. Zhu AX. Oncologist. 2006 Jul-Aug;11(7):790-800. doi: 10.1634/theoncologist.11-7-790. Oncologist. 2006. PMID: 16880238 Free article. Review.

7

Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors.

Ryan DP, Appleman LJ, Lynch T, Supko JG, Fidias P, Clark JW, Fishman M, Zhu AX, Enzinger PC, Kashala O, Cusack J Jr, Eder JP. Ryan DP, et al. Among authors: zhu ax. Cancer. 2006 Nov 15;107(10):2482-9. doi: 10.1002/cncr.22264. Cancer. 2006. PMID: 17036355 Free article. Clinical Trial.

8

Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma.

Zhu AX, Stuart K, Blaszkowsky LS, Muzikansky A, Reitberg DP, Clark JW, Enzinger PC, Bhargava P, Meyerhardt JA, Horgan K, Fuchs CS, Ryan DP. Zhu AX, et al. Cancer. 2007 Aug 1;110(3):581-9. doi: 10.1002/cncr.22829. Cancer. 2007. PMID: 17583545 Free article. Clinical Trial.

9

Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma.

Zhu AX. Zhu AX. Cancer. 2008 Jan 15;112(2):250-9. doi: 10.1002/cncr.23175. Cancer. 2008. PMID: 18041064 Free article.

10

Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma.

Zhu AX, Holalkere NS, Muzikansky A, Horgan K, Sahani DV. Zhu AX, et al. Oncologist. 2008 Feb;13(2):120-5. doi: 10.1634/theoncologist.2007-0174. Oncologist. 2008. PMID: 18305056 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

391 results

Search Page